文献速递肝病消化道肿瘤与早癌消化内镜

Child-Pugh B 肝硬化肝细胞癌肝切除术后结局列线图的开发

Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
PubMed 文献 · J Hepatol · 2019-09-06

本研究回顾性汇总 2002 至 2017 年 14 家国际中心 253 例 Child-Pugh B 肝硬化合并肝细胞癌行肝切除患者,评估术后风险与生存。90 天死亡率为 4.3%,5 年总生存率为 47%,并构建了手术风险、无病生存和总生存的预测模型。

要点

  • Child-Pugh B 肝硬化患者肝切除后 90 天死亡率为 4.3%,主要死因为肝衰竭。
  • 大范围肝切除与开腹手术分别与更高的死亡率和并发症率相关。
  • 基于患者特征、肿瘤模式与肝功能构建的预测模型有助于治疗分配。

核心结论

  • 经仔细选择患者后,Child-Pugh B 肝硬化合并肝细胞癌可考虑肝切除,目标是最小化手术应激。

研究设计与样本

  • 回顾性汇总 2002 至 2017 年 14 家国际转诊中心的 253 例 Child-Pugh B 肝硬化肝细胞癌肝切除患者。

主要发现

  • 57.3% 患者术前血小板计数 <100,000/mm3,43.5% 有术前腹水,56.9% 有门静脉高压。
  • 84.6% 行小范围肝切除,48.2% 接受微创手术;90 天死亡率为 4.3%,6 例(2.3%)死于肝衰竭。
  • 42.7% 患者发生并发症,最常见为腹水(37.5%)。
  • 大范围肝切除患者 90 天死亡率(10.3% vs. 3.3%;p = 0.04)和并发症率(69.2% vs. 37.9%;p <0.001)更高。
  • 开腹肝切除患者并发症率高于微创手术(52.7% vs. 31.9%;p = 0.001);5 年总生存率为 47%,56.9% 患者复发。

关键数值与推荐

  • 构建了手术风险预测模型(https://childb.shinyapps.io/morbidity/)、总生存预测模型(https://childb.shinyapps.io/survival/)和无病生存预测模型(https://childb.shinyapps.io/DFsurvival/)。

临床怎么用

  • 根据患者特征、肿瘤模式和肝功能仔细选择 Child-Pugh B 肝硬化患者行肝切除,并优先考虑微创和小范围肝切除以降低手术应激。
  • 可利用手术风险与生存预测模型辅助治疗分配,以改善术后并发症并实现安全的肿瘤学结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Treatment allocation in patients with hepatocellular carcinoma (HCC) on a background of Child-Pugh B (CP-B) cirrhosis is controversial. Liver resection has been proposed in small series with acceptable outcomes, but data are limited. The aim of this study was to evaluate the outcomes of patients undergoing liver resection for HCC in CP-B cirrhosis, focusing on the surgical risks and survival. METHODS: Patients were retrospectively pooled from 14 international referral centers from 2002 to 2017. Postoperative and oncological outcomes were investigated. Prediction models for surgical risks, disease-free survival and overall survival were constructed. RESULTS: A total of 253 patients were included, of whom 57.3% of patients had a preoperative platelet count <100,000/mm3, 43.5% had preoperative ascites, and 56.9% had portal hypertension. A minor hepatectomy was most commonly performed (84.6%) and 122 (48.2%) were operated on by minimally invasive surgery (MIS). Ninety-day mortality was 4.3% with 6 patients (2.3%) dying from liver failure. One hundred and eight patients (42.7%) experienced complications, of which the most common was ascites (37.5%). Patients undergoing major hepatectomies had higher 90-day mortality (10.3% vs. 3.3%; p = 0.04) and morbidity rates (69.2% vs. 37.9%; p <0.001). Patients undergoing an open hepatectomy had higher morbidity (52.7% vs. 31.9%; p = 0.001) than those undergoing MIS. A prediction model for surgical risk was constructed (https://childb.shinyapps.io/morbidity/). The 5-year overall survival rate was 47%, and 56.9% of patients experienced recurrence. Prediction models for overall survival (https://childb.shinyapps.io/survival/) and disease-free survival (https://childb.shinyapps.io/DFsurvival/) were constructed. CONCLUSIONS: Liver resection should be considered for patients with HCC and CP-B cirrhosis after careful selection according to patient characteristics, tumor pattern and liver function, while aiming to minimize surgical stress. An estimation of the surgical risk and survival advantage may be helpful in treatment allocation, eventually improving postoperative morbidity and achieving safe oncological outcomes. LAY SUMMARY: Liver resection for hepatocellular carcinoma in advanced cirrhosis (Child-Pugh B score) is associated with a high rate of postoperative complications. However, due to the limited therapeutic alternatives in this setting, recent studies have shown promising results after accurate patient selection. In our international multicenter study, we provide 3 clinical models to predict postoperative surgical risks and long-term survival following liver resection, with the aim of improving treatment allocation and eventually clinical outcomes.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Berardi G, Morise Z, Sposito C, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol. 2019. PMID: 31499131. doi:10.1016/j.jhep.2019.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。